CLINICAL – SUBCLINICAL CHARACTERISTICS IN PATIENTS WITH BENIGN THYROID TUMOR TREATED BY TOETVA

Nguyễn Xuân Hậu1,2,, Lê Đức Anh1
1 Hanoi Medical University
2 Hanoi Medical University Hospital

Main Article Content

Abstract

Objects:To evaluate the clinical – paraclinical characteristics in patientswith benign thyroid tumorwho were treated by TOETVA in Hanoi Medical University Hospital. Subjects and Methods:A prospective study was performed on 342 eligible patients who underwent TOETVA due to benign thyroid tumorat Department of Oncology and Palliative Care, Hanoi Medical University Hospital from January 2020to Decembeber 2021. Results: The mean age was 36,9 ± 10,6 years. The average tumor size was là 26,9±12,4 (4,0 – 61,0)mm. Most of the tumors were found in 1 lobe of the thyroid gland, the rate of tumors in both thyroid lobes was 23,7%. 100% of the patients hadfine needle aspiration resultsbenign or atypia of undetermined significance (category II or III according to Bethasda 2017 classification). 6,1%, 87,8% and 6,1% of patients underwent total thyroidectomy, lobectomy and lobectomy with contralateral tumor resection, respectively. Mean surgical time ofTOETVAwas 98,2±33,4 min. Conclusions: Giantbenign thyroid tumor was treated by TOETVA.

Article Details

References

1. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1-133.
2. Diagnostic approach to and treatment of thyroid nodules - UpToDate. Accessed May 24, 2021. https://www.uptodate.com/contents/diagnostic-approach-to-and-treatment-of-thyroid-nodules
3. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules - 2016 Update Appendix - Endocrine Practice. Accessed May 28, 2021. https://www.endocrinepractice.org/article/S1530-891X(20)42954-4/fulltext
4. Anuwong A. (2016). Transoral Endoscopic Thyroidectomy Vestibular Approach: A Series of the First 60 Human Cases. World J Surg, 40(3), 491–497.
5. Xuan H.N., Le H.T., Xuan H.N., et al. (2021). Preliminary Experience with Transoral Endoscopic Thyroidectomy and Parathyroidectomy via Vestibular Approach. 25(1), 11.
6. Nguyen H.X., Nguyen H.X., Nguyen H.V., et al. (2021). Transoral Endoscopic Thyroidectomy by Vestibular Approach with Central Lymph Node Dissection for Thyroid Microcarcinoma. Journal of Laparoendoscopic & Advanced Surgical Techniques, 31(4), 410–415.
7. Anuwong A., Ketwong K., Jitpratoom P., et al. (2018). Safety and Outcomes of the Transoral Endoscopic Thyroidectomy Vestibular Approach. JAMA Surg, 153(1), 21
8. Nguyen H.X., Nguyen H.X., Nguyen T.T.P., et al. (2022). Transoral endoscopic thyroidectomy by vestibular approach in Viet Nam: surgical outcomes and long-term follow-up. Surg Endosc, 36(6), 4248–4254.
9. Nguyen HX, Nguyen LT, Nguyen HV, et al. Comparison of Transoral Thyroidectomy Vestibular Approach and Unilateral Axillobreast Approach for Endoscopic Thyroidectomy: A Prospective Cohort Study. J Laparoendosc Adv Surg Tech. 2020;31(1):11-17.